(Q54360606)

28 May 2018

title

ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study. (English)

1 reference

28 May 2018

main subject

papillary thyroid cancer

1 reference

Qiu-li Li

1

1 reference

28 May 2018

Fu-jin Chen

2

1 reference

28 May 2018

Renchun Lai

3

1 reference

28 May 2018

Zhu-ming Guo

4

1 reference

28 May 2018

Rongzhen Luo

5

1 reference

28 May 2018

An-kui Yang

6

1 reference

28 May 2018

publication date

8 July 2011

1 reference

28 May 2018

published in

Medical Oncology

1 reference

28 May 2018

volume

29

1 reference

28 May 2018

issue

3

1 reference

28 May 2018

page(s)

1409-1417

1 reference

28 May 2018

Management of simple nodular goiter: current status and future perspectives

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Thyroid nodules: rational management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Discrimination of benign and malignant thyroid nodules by molecular profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Sizn1 is a novel protein that functions as a transcriptional coactivator of bone morphogenic protein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Evidence that SIZN1 is a candidate X-linked mental retardation gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

SUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Human ZCCHC12 activates AP-1 and CREB signaling as a transcriptional co-activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0018-6

Using gene expression profiling to differentiate benign versus malignant thyroid tumors

21 January 2018

1 reference

12 December 2020

Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors

1 reference

12 December 2020

Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications

1 reference

12 December 2020

Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care

1 reference

12 December 2020

Cancer statistics, 2010

1 reference

12 December 2020

Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association

1 reference

12 December 2020

Effect of iodine intake on thyroid diseases in China

1 reference

12 December 2020

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

12 December 2020

Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia

1 reference

12 December 2020

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

12 December 2020

10.1007/S12032-011-0018-6

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018